| Trial ID: | L0101 |
| Source ID: | NCT02733510
|
| Associated Drug: |
Methylprednisolone
|
| Title: |
The Impact of Early Protocol Biopsy in Kidney Transplant
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Failure
|
| Interventions: |
DRUG: methylprednisolone
|
| Outcome Measures: |
Primary: biopsy proven acute rejection event, within 1 year after renal transplantation|incidence of opportunistic infection, within 1 year after renal transplantation | Secondary: histologic feature at 1 year protocol biopsy, 1 year after renal transplantation
|
| Sponsor/Collaborators: |
Sponsor: Samsung Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
200
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2016-04
|
| Completion Date: |
2019-04
|
| Results First Posted: |
|
| Last Update Posted: |
2016-04-11
|
| Locations: |
Samsung Medical Center, Organ Transplant Center, Seoul, 135-710, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02733510
|
